|1.||Kamaleshwaran, Koramadai Karuppusamy: 3 articles (05/2015 - 01/2012)|
|2.||Mittal, Bhagwant Rai: 3 articles (07/2012 - 07/2011)|
|3.||Bhattacharya, Anish: 3 articles (07/2012 - 07/2011)|
|4.||Mohanan, Vyshakh: 2 articles (05/2015 - 10/2013)|
|5.||Shinto, Ajit Sugunan: 2 articles (05/2015 - 10/2013)|
|6.||Karunanithi, Sellam: 2 articles (12/2014 - 08/2014)|
|7.||Bal, Chandrasekhar: 2 articles (12/2014 - 08/2014)|
|8.||Kumar, Rakesh: 2 articles (12/2014 - 08/2014)|
|9.||Sharma, Punit: 2 articles (12/2014 - 08/2014)|
|10.||Jia, Qiang: 2 articles (08/2011 - 09/2009)|
|1.||Neoplasm Metastasis (Metastasis)
09/01/2000 - "The purpose of this study was to compare positron emission tomography using fluorine-18 fluorodeoxyglucose (FDG-PET) and technetium-99m methylene diphosphonate (MDP) bone scintigraphy in the detection of osseous metastases from malignant primary osseous tumours. "
10/01/2015 - "Ten patients with stage IV RCC and bone metastases were imaged with (18)F-NaF PET/CT and (99m)Tc-labelled methylene diphosphonate ((99m)Tc-MDP) bone scintigraphy including pelvic single photon emission computed tomography (SPECT). "
01/01/2014 - "(99)Tc(m)-MDP ((99)Tc(m) marked methylene diphosphonate) bone imaging could diagnosis the bone metastasis with highly sensitivity, but with lower specificity. "
10/01/2013 - "Technetium-99m methylene diphosphonate scintigraphy is usually performed to assess bone lesions, especially skeletal metastases in patients with a history of malignancy. "
03/01/2012 - "Technetium-99m methylene diphosphonate (Tc-99m MDP) whole-body bone scintigraphy (BS) has been widely used for detecting bone metastases. "
01/01/1990 - "This study describes the results of scintigraphy with 99mTc-labeled methylene-diphosphonate (99mTc-MDP) and pyrophosphate (99mTc-PYP) as a noninvasive test for the distribution of organ involvement in five different types of amyloidosis. "
10/01/1986 - "[Primary systemic amyloidosis with polyneuropathy as the major symptom demonstrating marked myocardial uptake of technetium-99m-hydroxy methylene diphosphonate]."
07/01/1983 - "A prospective, comparative study was made of the efficacy of technetium-99m pyrophosphate (Tc PYP) and technetium-99m methylene diphosphonate (Tc MDP) in detecting soft-tissue amyloidosis. "
01/01/1990 - "Pulmonary deposition of technetium 99m methylene diphosphonate was found on a bone scan of a patient with undiagnosed primary AL amyloidosis. "
03/01/1985 - "To assess the clinical significance of technetium-99m-pyrophosphate (Tc-99m-PYP), -methylene diphosphonate (Tc-99m-MDP) and thallium-201 (Tl-201) myocardial scintigraphy in the diagnosis of cardiac amyloidosis and in the differential diagnosis of cardiac diseases, 12 patients with biopsy-proved systemic amyloidosis (seven with familial amyloid polyneuropathy (FAP) and five with primary amyloidosis) were investigated. "
04/01/1992 - "30 patients with suspected bone infection underwent three-phase methylene diphosphonate (MDP) bone imaging and labelled leukocyte imaging on separate occasions. "
01/01/1996 - "Twenty-two adult diabetic patients with clinical suspicion of foot and/or ankle infection were prospectively evaluated using radiography, technetium-99m methylene diphosphonate bone scanning (99mTc), indium-111-labeled leukocyte scanning (111In), and gallium-67 scanning (67Ga) to determine the presence of clinically suspected osteomyelitis. "
01/01/1992 - "Imaging with technetium-99m methylene diphosphonate (99mTc-MDP) is established in the diagnosis of infection, neoplasia and ischaemic necrosis in orthopaedic practice, but its role in fracture healing is less well-defined. "
04/01/1988 - "Acute osteomyelitis, soft-tissue infection, or both were experimentally produced in 38 New Zealand white rabbits, and three-phase technetium-99m methylene diphosphonate, gallium-67, and magnetic resonance (MR) images were obtained 7 or 14 days after infection. "
12/01/1992 - "The efficacy of 111In WBCs was compared to gallium 67 citrate (67Ga) and technetium Tc99m methylene diphosphonate (99mTc MDP) scintigraphy in detecting and monitoring the resolution of infection. "
11/01/1980 - "Forty patients, ages three days to 12 years, with neuroblastomas had bone scans with 99mtechnetium methylene diphosphonate (99mTc-MDP) as part of their pretreatment examination. "
11/01/1980 - "Primary neuroblastoma uptake of 99mtechnetium methylene diphosphonate."
01/01/1980 - "Extraosseous uptake of 99mtechnetium methylene diphosphonate: neuroblastoma or radiation therapy."
12/04/1978 - "A case of primary neuroblastoma in a seven year old boy is presented in which 99Tcm methylene diphosphonic acid (MDP) used as a bone scanning agent localised in the primary tumour. "
12/04/1978 - "Extra-osseous localisation of 99Tcm methylene diphosphonic acid (MDP) in a primary neuroblastoma."
|5.||Osteonecrosis (Kienbock's Disease)
|1.||Technetium (Technetium 99m)
|3.||Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
|4.||Technetium Tc 99m Pyrophosphate
|6.||Citric Acid (Citrate)
|8.||Immunoglobulin M (IgM)
|9.||Immunoglobulin G (IgG)
|10.||Immunoglobulin A (IgA)
|2.||Hip Replacement Arthroplasty (Total Hip Replacement)